817 related articles for article (PubMed ID: 9205097)
1. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
2. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
Eliopoulos AG; Dawson CW; Mosialos G; Floettmann JE; Rowe M; Armitage RJ; Dawson J; Zapata JM; Kerr DJ; Wakelam MJ; Reed JC; Kieff E; Young LS
Oncogene; 1996 Nov; 13(10):2243-54. PubMed ID: 8950992
[TBL] [Abstract][Full Text] [Related]
3. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
[TBL] [Abstract][Full Text] [Related]
5. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
6. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
[TBL] [Abstract][Full Text] [Related]
7. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
8. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
Huen DS; Henderson SA; Croom-Carter D; Rowe M
Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
Liebowitz D
N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
[TBL] [Abstract][Full Text] [Related]
11. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.
Yamamoto H; Kishimoto T; Minamoto S
J Immunol; 1998 Nov; 161(9):4753-9. PubMed ID: 9794406
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
14. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
[TBL] [Abstract][Full Text] [Related]
15. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
Hostager BS; Bishop GA
J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
[TBL] [Abstract][Full Text] [Related]
18. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
20. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
